Equities

Rapid Nutrition PLC

ALRPD:PAR

Rapid Nutrition PLC

Actions
  • Price (EUR)0.0717
  • Today's Change0.00 / 0.00%
  • Shares traded215.11k
  • 1 Year change-94.03%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rapid Nutrition PLC is a United Kingdom-based natural healthcare company focused on research, development and production of a range of evidence-based nutrition. The Company is engaged in the development and distribution of science-based health and wellness brands across the globe. The Company's core business is the creation of organic and natural scientific-based health food supplements and building them into brands. Its flagship brands include System LS and Leisa's Secret. System LS includes six products. Each product provides natural and organic ingredients designed to support weight loss. Further, the products include a phone application, which offers ongoing motivation for consumers. Each component of Leisa's Secret Advanced Weight Loss System is also designed to support weight loss. In addition to its own flagship brands, the Company continues to expand its product offering by representing various market nutrition brands.

  • Revenue in EUR (TTM)1.82m
  • Net income in EUR-1.45m
  • Incorporated2012
  • Employees9.00
  • Location
    Rapid Nutrition PLC124 City RoadLONDON EC1V 2NXUnited KingdomGBR
  • Phone+44 203 239 2561
  • Websitehttps://www.rnplc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
2cureX AB13.31k-2.65m531.96k----0.4526--39.98-1.75-1.750.00880.77770.0048--0.0838---95.89-38.21-108.66-43.48-6,889.68-22,153.06-19,883.23-38,685.30---46.08----72.22---3.52------
Lipidor AB6.61k-986.09k537.34k--------81.29-0.3964-0.39640.0027-0.32230.0084--5.31---124.54-59.41---75.10-----14,916.88-643.36--------73.33-20.3372.24------
XP Chemistries AB56.98k-690.15k561.43k2.00--0.2546--9.85-0.2846-0.28460.02130.2750.0230.20845.99331,845.00-27.79---29.36--50.57---1,211.24--5.79--0.00---37.14---1.55------
Stayble Therapeutics AB0.00-2.04m679.46k3.00--0.4794-----0.9492-0.94920.000.52040.00----0.00-116.21-78.64-141.76-95.58------------0.049------3.22------
Ovoca Bio PLC0.00-2.33m689.33k5.00--0.1363-----0.0245-0.02450.000.05310.00----0.00-27.00-17.82-32.86-19.39--------4.68-48.640.00-------6.96------
CoDon AG9.84m-14.13m734.55k134.00--0.1115--0.0747-0.5513-0.55130.40180.24680.51610.986410.1073,432.84-74.08-41.86-86.85-48.5394.1091.39-143.53-139.570.8393-21.920.4887--57.2811.8632.79--24.07--
Voyager Life PLC366.82k-1.29m736.13k28.00--0.9933--2.01-0.0912-0.09120.02530.0440.18971.583.8511,214.29-66.51---77.02--41.72---350.64--2.83-69.500.4625--59.55---38.70------
Eurocine Vaccines AB429.00-1.29m810.60k3.00------1,888.38-0.1472-0.14720.00005-0.00180.0007--0.002---199.76-83.17-323.19-97.89-199,780.00---301,180.00--------------8.95------
Carbiotix AB (publ)145.99k-1.25m851.00k10.00--0.3686--5.83-0.2357-0.23570.01960.14920.0658--3.43170,052.00-56.32-49.38-62.10-55.50201.79574.69-855.62-1,828.86---45.740.00--259.56-12.04-10.02--13.64--
Amniotics AB (publ)0.00-2.65m915.08k6.00--0.6803-----0.0374-0.03740.000.00570.00----0.00-112.25-101.09-362.71-149.92--------1.12-16.17--------35.75------
Rapid Nutrition PLC1.82m-1.45m931.84k9.0039.78549.92--0.51190.00170.00170.00340.00011.843.903.05202,244.60-146.98---1,011.07--71.47---79.74--1.07--0.7674---1.50---1,090.33------
Diagonal Bio AB1.98k-1.00m1.09m4.00--0.0984--552.18-0.1982-0.19820.00040.32210.0007--2.005,750.00-37.35---44.49---41,604.35---50,769.57--0.5105-104.20-----88.67--27.75------
Data as of May 16 2024. Currency figures normalised to Rapid Nutrition PLC's reporting currency: Euro EUR

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Herculis Partners SAas of 31 Jan 20201.35k0.01%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.